Correlation of percutaneous liver biopsy fragmentation with the degree of fibrosis

Aliment Pharmacol Ther. 2004 Mar 1;19(5):545-9. doi: 10.1111/j.1365-2036.2004.01882.x.

Abstract

Background: Although fragmentation of a liver biopsy specimen has been considered to be suggestive of cirrhosis, the evidence for this is difficult to find in the published literature.

Aim: To determine whether fragmentation of percutaneous liver biopsy specimens correlates with the degree of fibrosis.

Methods: One hundred and eighty-six patients underwent percutaneous liver biopsy prospectively. The specimens were measured for the length and number of fragments. The extent of fibrosis was scored by a pathologist blind to the clinical data. Length and fragmentation data were compared between the different stages.

Results: The overall median fragment length was 1.85 cm and the median fragment number was four. Specimens with advanced fibrosis (stages III-IV) had more fragments than those with no or mild fibrosis (stages 0-II) (P < 0.0001). The aggregate fragment length decreased with increasing stage of fibrosis (P < 0.0001). Specimens with greater than 12 fragments were seen only with advanced fibrosis.

Conclusions: Fragmentation of percutaneous liver biopsy specimens is common and increases with progression from early to advanced fibrosis. Fibrotic specimens fragment more often and more extensively.

MeSH terms

  • Adult
  • Aged
  • Biopsy, Needle
  • Hepatitis C, Chronic / pathology
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis / pathology*
  • Middle Aged
  • Prospective Studies
  • Specimen Handling